Skip to main content
. 2023 Dec 26;2023:5544440. doi: 10.1155/2023/5544440

Table 6.

Outcomes of patients in the clopidogrel and ticagrelor groups.

Clopidogrel (n = 223) Ticagrelor (n = 214) P value
Major adverse cardiac events 17 (7.6%) 6 (2.8%) 0.031
Acute coronary syndrome, n (%) 14 (6.2%) 6 (2.8%)
Heart failure, n (%) 1 (0.4%) 0
Cerebrovascular events, n (%) 1 (0.4%) 0
Cardiac death, n (%) 1 (0.4%) 0
Noncardiac death, n (%) 3 (1.3%) 1 (0.4%) 0.371
Bleeding, n (%) 7 (3.2%) 8 (3.8%) 0.799